<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00374582</url>
  </required_header>
  <id_info>
    <org_study_id>BIA</org_study_id>
    <nct_id>NCT00374582</nct_id>
  </id_info>
  <brief_title>End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)</brief_title>
  <official_title>End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to see how effective bioelectric impedance analysis
      (BIA) is in determining body composition (the amount of fat versus muscle in the body) and
      nutritional status in patients with End Stage Liver Disease (ESLD)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to report the validity of mBIA to determine body composition changes
      pre and post LVP (Large Volume Paracentesis)

        -  18 years of age or older

        -  Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large
           volumes of excess fluid from the abdominal cavity)

        -  End Stage Liver Disease
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy and utility of BIA in determining body composition and nutritional status using multi-frequency machines in patients with ESLD and ascites requiring LVP.</measure>
    <time_frame>Before and after large volume paracentesis</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantify the difference in BIA pre and post LVP to evaluate the impact of oncotic pressure in the assessment of total body composition.</measure>
    <time_frame>Before and after large volume paracentis</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>End Stage Liver Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bodystat Quadscan 4000</intervention_name>
    <description>device determining body composition and nutritional status</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>bodystat quadscan 400</intervention_name>
    <description>device determining body composition and nutritional status</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with ESLD requiring LVP.

          -  Age over 18.

          -  Ability to provide written informed consent.

        Exclusion Criteria:

          -  Organ retransplant candidates.

          -  Patient with use of any investigational agent within 30 days before LVP.

          -  Pregnant or lactating.

          -  Patients with non-bioprosthetic heart valves pacemakers, defibrillators, artificial
             joints, pins, plates, or other types of metal objects in the body.

          -  Amputations other than fingers or toes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guy Neff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2006</study_first_submitted>
  <study_first_submitted_qc>September 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2006</study_first_posted>
  <last_update_submitted>March 3, 2011</last_update_submitted>
  <last_update_submitted_qc>March 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Guy Neff, MD</name_title>
    <organization>University of Cincinnati</organization>
  </responsible_party>
  <keyword>Bioelectric impedance analysis</keyword>
  <keyword>BIA</keyword>
  <keyword>ESLD</keyword>
  <keyword>LVP</keyword>
  <keyword>Large volume paracentesis</keyword>
  <keyword>Ascites</keyword>
  <keyword>Liver</keyword>
  <keyword>Hepatic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 9, 2012</submitted>
    <returned>February 8, 2012</returned>
    <submitted>June 14, 2012</submitted>
    <returned>July 13, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

